Retraction: MicroRNA-138 acts as a tumor suppressor in non small cell lung cancer via targeting YAP1.

Autor: Xiao L; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Hunan 410078, P.R. China.; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan 410078, P.R. China.; Department of Histology and Embryology, School of Basic Medical Sciences, Central South University, Changsha, Hunan 410013, P.R. China., Zhou H; The Affiliated Cancer Hospital, XiangYa School of Medicine, Central South University, Changsha, Hunan 410014, P.R. China., Li XP; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Hunan 410078, P.R. China.; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan 410078, P.R. China., Chen J; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Hunan 410078, P.R. China.; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan 410078, P.R. China., Fang C; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Hunan 410078, P.R. China.; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan 410078, P.R. China., Mao CX; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Hunan 410078, P.R. China.; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan 410078, P.R. China., Cui JJ; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Hunan 410078, P.R. China.; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan 410078, P.R. China., Zhang W; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Hunan 410078, P.R. China.; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan 410078, P.R. China., Zhou HH; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Hunan 410078, P.R. China.; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan 410078, P.R. China., Yin JY; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Hunan 410078, P.R. China.; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan 410078, P.R. China., Liu ZQ; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Hunan 410078, P.R. China.; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan 410078, P.R. China.
Jazyk: angličtina
Zdroj: Oncotarget [Oncotarget] 2024 Aug 26; Vol. 15, pp. 590. Date of Electronic Publication: 2024 Aug 26.
DOI: 10.18632/oncotarget.28645
Databáze: MEDLINE